Spliced analogues of trypsin inhibitor SFTI-1 and their application for tracing proteolysis and delivery of cargos inside the cells
Magdalena Filipowicz , Natalia Ptaszyńska , Katarzyna Olkiewicz , Dawid Dębowski , Kamila Ćwikłowska , Timo Burster , Michał Pikuła , Adam Krzystyniak , Anna Łęgowska , Krzysztof Rolka
AbstractA series of analogues of trypsin inhibitor SFTI‐1 were designed and synthesized to monitor peptide splicing. In the middle part of the SFTI‐1 analogues, which is released upon incubation with proteinase, the RGD sequence or an acceptor of fluorescence for FRET was introduced. The results of studies with trypsin confirmed that the designed analogues underwent peptide splicing. Furthermore, we showed that a FRET displaying SFTI‐1 analogue was internalized into the HaCaT keratinocytes, where it was degraded. Therefore, both proteolysis and the reduction of the disulfide bridge of the peptide took place. As a result, such analogues are a convenient tool to trace the proteolytic activity inside the cell. However, the cytotoxicity of SFTI‐1 analogues grafted with the RGD sequence did not correlate with their susceptibility to peptide splicing. Nevertheless, these peptides were slightly more active than the reference peptide (GRGDNP). Interestingly, one of the analogues assigned as [desSer6]VI, under experimental conditions, appeared significantly more cytotoxic towards cancer cells U87‐MG in contrast to the reference peptide.
|Journal series||Biopolymers, ISSN 0006-3525, e-ISSN 1097-0282, (A 25 pkt)|
|Publication size in sheets||1.25|
|Keywords in English||peptide splicing, SFTI-1 analogues, inhibitors, proteolysis, FRET, RGD peptides|
|ASJC Classification||; ; ; ;|
|Score||= 25.0, 24-07-2019, ArticleFromJournal|
|Publication indicators||= 3; : 2016 = 0.722; : 2017 = 1.99 (2) - 2017=2.165 (5)|
* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.